WallStSmart
TENX

Tenax Therapeutics Inc

NASDAQ: TENX · HEALTHCARE · BIOTECHNOLOGY

$11.95
+2.97% today

Updated 2026-06-04

Market cap
$284.62M
P/E ratio
P/S ratio
414.72x
EPS (TTM)
$-1.41
Dividend yield
52W range
$5 – $18
Volume
0.6M

Tenax Therapeutics Inc (TENX) Financial statements

SEC filings — annual and quarterly data.

Profit margin
0.00%
Operating margin
0.00%
ROE
-50.49%
ROA
-32.70%
Debt/equity

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2006$-25633.00$-3.33M100.00%9,669.53%12,994.46%
2007$-24131.00$-3.33M100.00%7,344.95%13,803.28%
2008$-6.72M
2009$47386.00$-10.51M17.63%-21,528.50%-22,174.01%
2010$322349.00$-10.45M-64.48%-3,276.78%-3,241.30%
2011$415034.00$-15.71M87.65%-1,980.61%-3,785.81%
2012$288726.00$-19.54M55.04%-5,844.34%-6,768.30%
2013$288726.00$-19.54M55.04%-5,753.25%-6,768.30%
2014$49286.00$-14.08M100.00%-27,775.19%-28,571.63%
2015$49286.00$-14.08M80.26%-31,729.59%-28,571.63%
2016$0.00$-43.92M
2017$0.00$-8.84M
2018$0.00$-6.81M
2019$0.00$-8.39M
2020$0.00$-9.85M
2021$0.00$-32.47M
2022$0.00$-11.05M
2023$0.00$-7.71M
2024$0.00$-17.60M
2025$0.00$-52.60M

Frequently asked questions

How much free cash flow does TENX generate?

TENX produced $-35.80M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is TENX's balance sheet healthy?

TENX holds $97.56M in cash and equivalents against — in long-term debt, on $97.07M of shareholder equity. That debt is best read against the cash flow the business throws off each year.